Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation-Reference-Cited by-同舟云学术

Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation

Published:2019 Issue:43 Volume:10 Page:10149-10158
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Yang Tao¹²³⁴⁵^ORCID,Zhu Zhenzhu¹²³⁴⁵^ORCID,Yin Enmao¹²³⁴⁵,Wang Yanqing⁶⁷⁸⁵,Zhang Changli⁹¹⁰¹¹⁵,Yuan Hao¹²⁶³⁴⁵,Zhang Hongmei¹²³⁴⁵,Jin Suxing¹²³⁴⁵^ORCID,Guo Zijian¹²⁶³⁴⁵^ORCID,Wang Xiaoyong¹²³⁴⁵^ORCID

Affiliation:

1. State Key Laboratory of Pharmaceutical Biotechnology

2. School of Life Sciences

3. Nanjing University

4. Nanjing 210023

5. P. R. China

6. School of Chemistry and Chemical Engineering

7. Yancheng Teachers University

8. Yancheng 224002

9. Department of Chemistry

10. Nanjing Xiaozhuang College

11. Nanjing

12. State Key Laboratory of Coordination Chemistry

Abstract

Neuromodulator BIBA inhibits Aβ aggregation and suppresses neuroinflammation in vitro and in vivo, showing prominent anti-AD potential through a synergistic mechanism.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/SC/C9SC03042E

Reference74 articles.

1. Alzheimer's Disease

2. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

3. Current Pharmacotherapy for Alzheimer's Disease